Biotricity Cash Flow from Investing Activities 2015-2023 | BTCY
Biotricity cash flow from investing activities from 2015 to 2023. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| Biotricity Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $-0 |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| 2018 | $ |
| 2017 | $ |
| 2016 | $ |
| 2015 | $ |
| 2015 | $ |
| 2015 | $ |
| 2014 | $ |
| 2014 | $ |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.011B | $0.010B |
| Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.947B | 19.74 |
| Inspire Medical Systems (INSP) | United States | $4.693B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.102B | 0.00 |
| Axonics (AXNX) | United States | $3.425B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.987B | 0.00 |
| Azenta (AZTA) | United States | $2.753B | 154.79 |
| IRhythm Technologies (IRTC) | United States | $2.730B | 0.00 |
| Enovis (ENOV) | United States | $2.727B | 20.21 |
| 10x Genomics (TXG) | United States | $2.705B | 0.00 |
| Privia Health (PRVA) | United States | $2.062B | 115.20 |
| Schrodinger (SDGR) | United States | $1.607B | 0.00 |
| Omnicell (OMCL) | United States | $1.488B | 51.43 |
| Phreesia (PHR) | United States | $1.296B | 0.00 |
| Standard BioTools (LAB) | United States | $0.936B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.647B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.645B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.501B | 0.00 |
| Talkspace (TALK) | United States | $0.480B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.403B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| Pulmonx (LUNG) | United States | $0.311B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.217B | 0.00 |
| Outset Medical (OM) | United States | $0.206B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.171B | 0.00 |
| TruBridge (TBRG) | United States | $0.146B | 7.87 |
| American Well (AMWL) | United States | $0.128B | 0.00 |
| 111 (YI) | China | $0.109B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.102B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.080B | 0.00 |
| HeartBeam (BEAT) | United States | $0.077B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.068B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.057B | 0.00 |
| Augmedix (AUGX) | United States | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.046B | 0.00 |
| CareCloud (CCLD) | United States | $0.044B | 0.00 |
| Movano (MOVE) | United States | $0.040B | 0.00 |
| Akili (AKLI) | United States | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| Cue Health (HLTH) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |